Suppr超能文献

HIV 相关隐球菌性脑膜炎:弥合发达国家与资源有限地区之间的差距

HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings.

作者信息

Tenforde Mark W, Wake Rae, Leeme Tshepo, Jarvis Joseph N

机构信息

Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, WA USA ; University of Washington Medical Center, 1959 NE Pacific Street, Health Sciences Division #356423, Seattle, WA 98195 USA.

Institute of Infection and Immunity, St. George's University of London, London, UK ; Centre for Opportunistic, Tropical and Hospital Infections, National Institute for Communicable Diseases, Johannesburg, South Africa ; National Institute for Communicable Diseases, 1 Modderfontein Road, Sandringham, Johannesburg, 2131 South Africa.

出版信息

Curr Clin Microbiol Rep. 2016;3:92-102. doi: 10.1007/s40588-016-0035-5. Epub 2016 Mar 17.

Abstract

Cryptococcal meningitis is a major cause of HIV-associated morbidity and mortality worldwide. Most cases occur in low-income countries, where over half of patients die within 10 weeks of diagnosis compared to as few as 10 % of patients from developed countries. A host of factors, spanning the HIV care continuum, are responsible for this gap in treatment outcomes between developed and resource-limited settings. We explore factors responsible for this outcomes gap and describe low-cost, highly effective measures that can be implemented immediately to improve outcomes in resource-limited settings. We also explore health-system challenges that must be addressed to reduce mortality further, recent research in disease prevention, and novel short-course treatment regimens that, if efficacious, could be implemented in resource-limited settings where the cost of standard treatment regimens is currently prohibitive.

摘要

隐球菌性脑膜炎是全球范围内与艾滋病相关的发病和死亡的主要原因。大多数病例发生在低收入国家,这些国家超过一半的患者在诊断后10周内死亡,而发达国家只有10%的患者死亡。从艾滋病护理的整个过程来看,许多因素导致了发达国家和资源有限地区在治疗结果上的这种差距。我们探讨造成这种结果差距的因素,并描述可以立即实施的低成本、高效措施,以改善资源有限地区的治疗结果。我们还探讨了为进一步降低死亡率必须解决的卫生系统挑战、疾病预防方面的最新研究,以及新型短疗程治疗方案,如果这些方案有效,可在资源有限地区实施,因为目前标准治疗方案的成本过高。

相似文献

1
HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings.
Curr Clin Microbiol Rep. 2016;3:92-102. doi: 10.1007/s40588-016-0035-5. Epub 2016 Mar 17.
2
Treatment for HIV-associated cryptococcal meningitis.
Cochrane Database Syst Rev. 2018 Jul 25;7(7):CD005647. doi: 10.1002/14651858.CD005647.pub3.
3
Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Cochrane Database Syst Rev. 2008 Oct 8(4):CD005647. doi: 10.1002/14651858.CD005647.pub2.
7
Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.
PLoS Med. 2012;9(9):e1001316. doi: 10.1371/journal.pmed.1001316. Epub 2012 Sep 25.
9
Cryptococcal antigen screening and early antifungal treatment to prevent cryptococcal meningitis: a review of the literature.
J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S331-9. doi: 10.1097/QAI.0000000000000484.

引用本文的文献

3
An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease.
J Fungi (Basel). 2023 Jun 6;9(6):647. doi: 10.3390/jof9060647.
4
Etiology of meningitis among adults in three quaternary hospitals in Mozambique, 2016-2017: The role of HIV.
PLoS One. 2022 May 11;17(5):e0267949. doi: 10.1371/journal.pone.0267949. eCollection 2022.
5
A global call for talaromycosis to be recognised as a neglected tropical disease.
Lancet Glob Health. 2021 Nov;9(11):e1618-e1622. doi: 10.1016/S2214-109X(21)00350-8.
6
The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells.
Pharmaceuticals (Basel). 2021 Apr 23;14(5):404. doi: 10.3390/ph14050404.
7
Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis.
PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0008983. doi: 10.1371/journal.pntd.0008983. eCollection 2021 Mar.

本文引用的文献

1
Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study.
Clin Infect Dis. 2016 Mar 1;62(5):581-587. doi: 10.1093/cid/civ936. Epub 2015 Nov 12.
2
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis.
Antimicrob Agents Chemother. 2015 Dec;59(12):7224-31. doi: 10.1128/AAC.01698-15. Epub 2015 Sep 8.
3
Cryptococcal Antigen Screening and Preemptive Treatment in a US Cohort of Patients With AIDS.
Clin Infect Dis. 2015 Nov 15;61(10):1632-4. doi: 10.1093/cid/civ559. Epub 2015 Jul 13.
5
Lumbar puncture refusal in sub-Saharan Africa: A call for further understanding and intervention.
Neurology. 2015 May 12;84(19):1988-90. doi: 10.1212/WNL.0000000000001561.
6
Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy.
Curr Trop Med Rep. 2015;2(2):81-89. doi: 10.1007/s40475-015-0045-z.
7
Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.
Clin Infect Dis. 2015 Aug 1;61(3):464-7. doi: 10.1093/cid/civ263. Epub 2015 Apr 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验